James Garnett

James Garnett is an accomplished researcher in the field of respiratory and fibrosis therapeutics, with a robust academic background including a PhD in Cell Physiology from the University of Newcastle-upon-Tyne. Professional experience spans various institutions, such as serving as a Postdoctoral Research Associate at St. George's University of London and leading significant projects at Evotec as Head of Respiratory and Fibrosis Therapeutic Areas. Currently, as Executive Director and Head of COPD & IPF Bioscience at AstraZeneca, James focuses on strategies for drug discovery and evaluation of therapeutic opportunities. Previous roles also include leadership positions at Boehringer Ingelheim and contributions to respiratory disease research at Newcastle University and Novartis. Notably, James led a Medical Research Foundation grant to enhance understanding of respiratory infections and immunity in cystic fibrosis.